|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ocular Therapeutix (NASDAQ: OCUL) through any online brokerage.
The latest price target for Ocular Therapeutix (NASDAQ: OCUL) was reported by Raymond James on October 18, 2021. The analyst firm set a price target for 29.00 expecting OCUL to rise to within 12 months (a possible 319.68% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $6.91 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s $Q3 earnings are confirmed for after-market on $November 4, 2021.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.